Non-invasive Urinary Biomarkers in Moyamoya Disease

Introduction: A major difficulty in treating moyamoya disease is the lack of effective methods to detect novel or progressive disease prior to the onset of disabling stroke. More importantly, a tool to better stratify operative candidates and quantify response to therapy could substantively compleme...

Descripción completa

Detalles Bibliográficos
Autores principales: Sesen, Julie, Driscoll, Jessica, Moses-Gardner, Alexander, Orbach, Darren B., Zurakowski, David, Smith, Edward R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Neurology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8047329/
https://www.ncbi.nlm.nih.gov/pubmed/33868159
http://dx.doi.org/10.3389/fneur.2021.661952

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8047329/
https://www.ncbi.nlm.nih.gov/pubmed/33868159
http://dx.doi.org/10.3389/fneur.2021.661952

Ejemplares similares